Adjuvant InterFeron After Curative Resection of HCV-related Hepatocellular Carcinoma in Elderly Patients: a Multicenter Randomized Controlled Trial
Phase 3
- Conditions
- HCV-related hepato cellular carcinoma
- Registration Number
- JPRN-UMIN000005455
- Lead Sponsor
- Tokyo University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1)Positive HBs-Ag 2)Other anticancer treatment or interferon therapy within 3 months before surgery. 3)Specific drug which is forbidden in this trial is needed. 4)Participating in other clinical trial regarding HCC 5)Autoimmune hepatitis, alcoholic hepatitis, etc. 6)Allergy for specific biologics 7)Severe postoperative complications 8)Asthma 9)Diabetes requiring insulin therapy 10)Severe hypertension 11)Heart disease that complicates perioperative treatments 12)Interstitial pneumonia 13)Psychiatric disorder 14)Malignant disease in other organ within 5 years 15)Moderate or severe renal dysfunction (estimated Ccr < 30ml/min) 16)Other reason that an attending doctor considers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurence free survival
- Secondary Outcome Measures
Name Time Method